Lub npe | Tirzepatide Txhaj Hmoov |
Kev coj dawb huv | 99% |
Kev tshwm sim | Dawb Lyophilized Hmoov |
Kev ua nom | Subcutaneous txhaj |
Qhov loj | 10Mg, 15mg, 20mg, 30mg |
Ywg dej | 3.0% |
Cov txiaj ntsig | Kho ntshav qab zib, txhim kho ntshav nru tswj |
Tirzepatide yog cov lus tshiab-nyob hauv insulinotropic polypictropic kev tswj hwm tau pom zoo ginonist kev ua kom tau zoo ginonist thiab kev tshawb xyuas ntawm lub plawv tsis ua haujlwm nrog kev txuag hluav taws xob thiab kev rog thiab tsis-cirrhotic tsis-cawv steatohepatitis. Lub theem 3 nce mus rau 1-5 chaw kuaj mob tau tsim los txheeb xyuas qhov ua tau zoo thiab kev nyab xeeb ib zaug txhaj lossis kev kho mob ntawm cov neeg muaj ntshav qab zib hom 2. Kev siv Tirzepatide hauv cov kev tshawb fawb soj ntsuam tau cuam tshuam nrog kev sib tw txo qis ntawm glycated femetas kev pheej hmoo xws li ntshav siab, visceral adiposity thiab circulating triglycerides. Tirzepatide tau zoo zam, nrog txoj kev pheej hmoo tsawg ntawm hypoglycaemia thaum siv tsis muaj insulin lossis insulin zais cia ntse rau GLP-1 tus kws tshaj lij kev nyab xeeb hauv GLP-1 tus neeg ua haujlwm hauv chav kawm. Raws li, cov ntaub ntawv pov thawj los ntawm cov chaw kuaj mob no qhia tias Tirzepatide muaj lub sijhawm tshiab rau kev ua kom qis dua ntawm glycated hemoglobin thiab lub cev hnyav rau cov neeg laus muaj hom 2 ntshav qab zib.